It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.


What are my growth treatment options?

Diagnosis is just the beginning of your growth journey. By now, you may have questions about your treatment options. Get started by reviewing the options below and speaking with your doctor about which one may work for you.

 


Omnitrope® flexible
treatment options

The information below should help you decide which option will best fit your needs. If you have questions on how to inject Omnitrope, an OmniSource® Nurse Trainer can walk you through each step of the injection process. The nurse can also show you how to safely store and dispose of used needles.

Omnitrope is taken via daily injection. There are 2 administration options available—a liquid-formulation pen, and a vial and syringe.1
 

Injection pen

An injection pen may be the best option if you or your child is uncomfortable around needles or you would prefer not to mix Omnitrope at home. The ready-to-use liquid cartridge eliminates the need to reconstitute or mix with a liquid.*

In the photo, two foams for injection of the drug Omnitrope.

Our pens offer flexible dosing in 5 mg and 10 mg, and a liquid cartridge that stays stable for 28 days after the first injection.

Omnitrope vial and syringe.

Vial and syringe

If you choose the vial and syringe option, you will learn how to safely mix Omnitrope at home. Your Nurse Trainer will demonstrate this during your injection training session.

NOTE: Lyophilized powder must be reconstituted (mixed with liquid) before use. Each 5.8 mg vial of Omnitrope comes with a 1.14 mL vial of bacteriostatic water preserved with benzyl alcohol to mix in a solution before injecting. It stays stable for 3 weeks once reconstituted.†

*Cartridge must be stored or refrigerated from 36°F (2°C) to 46°F (8°C).
†Vial must be stored in the refrigerator at 36°F (2°C) to 46°F (8°C).

 

Learn how to administer Omnitrope
Learn more about OmniSource Nurse Trainers
Drop Bar@1.5x


Starting Omnitrope
growth hormone treatment

Getting started

If this is the first time you or your child is being prescribed a growth hormone treatment, or if you or your child is switching from another brand of somatropin, your OmniSource team is here to help you get started on Omnitrope as quickly as possible.

Financial support

Our team makes it their priority to give you the best possible start to treatment by helping you navigate the insurance process and address financial questions.


 

Ongoing support

The OmniSource team can teach you how to inject safely at home and make sure you’re comfortable with your new treatment routine.


 

Learn more about OmniSource patient services
Group 27

Growth hormone treatment for adults

Sometimes, a pediatric patient continues growth hormone treatment into adulthood. Adults can also acquire a growth hormone disorder for a number of reasons, such as traumatic brain injury.1

Whether you’re continuing growth hormone treatment or starting it for the first time, our OmniSource team is ready to help.

Learn more
Chrome-rail-Thin 1@1.5x
OmniSource_4c_full colour


OmniSource Patient Support Services

Click below to learn more about our Nurse Trainers and injection support.

Learn more about OmniSource Nurse Trainers


Questions about Omnitrope?

FAQs

To learn more about Omnitrope and our comprehensive patient support services, see our FAQ page for frequently asked questions about Omnitrope.

 

Read FAQs

Contact Us

You can also call our OmniSource team at the number below. We can walk you through the process of getting started with Omnitrope.

Available: Monday – Friday, 8AM – 8PM ET

Phone: 877-456-6794

 

Indications and Important Safety Information

Indications
Omnitrope is a prescription medicine that contains human growth hormone and is used to treat:

  • Children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
  • Adults with either adult onset or childhood onset GHD

IMPORTANT SAFETY INFORMATION

Who should not take Omnitrope®?

Omnitrope should not be used by children or adults that have:

  • a critical illness caused by certain types of heart or stomach surgery, accidental trauma, or a sudden and severe breathing problem (respiratory failure)
  • Prader-Willi syndrome who are severely overweight or have a history of breathing problems including sleep apnea
  • cancer or other tumors
  • allergies to growth hormone or any of the ingredients in the medicine
  • certain types of eye problems caused by diabetes
  • closed bone growth plates

What should patients tell their healthcare provider before taking Omnitrope?

Patients should tell their healthcare provider about all of their medical conditions, including if they: 

  • have had heart or stomach surgery, trauma, or serious breathing
    problems
  • have or have had cancer or any tumor
  • have diabetes
  • take any prescription and non-prescription medicines, steroids, vitamins, or herbal supplements
  • are pregnant or breastfeeding, or plan to become pregnant or
    breastfeed 

What are the most common side effects of Omnitrope?

  • local reactions at the injection site (such as pain, numbness,
    redness and swelling)
  • headaches
  • swelling associated with fluid retention
  • pain in joints and muscle pain
  • carpal tunnel syndrome
  • tingling and numbness
  • high blood sugar (hyperglycemia/diabetes) and sugar in your urine
    (glucosuria)
  • unusual skin sensations
  • low levels of thyroid hormone (hypothyroidism)

Other possible side effects of Omnitrope are:

  • return of tumor or cancerous growths
  • headaches, changes in vision, nausea or vomiting (these may be
    symptoms of raised pressure in the brain which requires immediate
    medical attention)
  • hip and knee pain or a limp in children, that can be a sign of
    slipped capital femoral epiphysis
  • worsening of pre-existing curvature of the spine in children
    (scoliosis)
  • increased ear infections and ear disorders in children with Turner
    syndrome; check for cardiovascular disorders (hypertension,
    stroke)
  • intense pain and tenderness in the abdomen as consequence of an
    inflammation of the pancreas (pancreatitis)
  • gasping syndrome (decreased rate of breathing) in children from
    high levels of benzyl alcohol (an inactive ingredient)
  • Increased mortality in patients with Prader Willi and acute illness

Please see full Prescribing Information for Omnitrope.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.